mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.06 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.07 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.098 |
0.07 |